Skip to main content
. Author manuscript; available in PMC: 2011 Feb 3.
Published in final edited form as: Eur J Pharmacol. 2007 Mar 24;565(1-3):54–59. doi: 10.1016/j.ejphar.2007.03.023

Fig. 2.

Fig. 2

The anti-HIV-1 activity of the compounds is correlated with their binding affinity to cyclophilin A (A) and with their anti-PPIase activity (B).